3815 results for «215»

Filter By

3815 results

Mitral TEER: LIVE Educational Case from Hospital Álvaro Cunqueiro - Vigo, Spain

16 Nov 2025 – From PCR London Valves 2025

This live educational case from Hospital Álvaro Cunqueiro in Vigo, Spain, offers an in-depth look at Mitral TEER, including patient presentation, imaging analysis, operator strategy, and device overview. The session also features a recorded case from the Heart and Diabetes Center NRW in Germany, providing comprehensive...

Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions

18 Nov 2025 – From PCR London Valves 2025

This session examines the integrated role of heart failure therapies in the peri- and post-procedural management of patients undergoing surgical and transcatheter valve interventions. It reviews current and emerging clinical trial data, discusses identifying high-risk patients, and explores advanced modalities such as cardiac resynchronization and circulatory...

TAVI - Haemodynamic performance and valve durability

18 Nov 2025 – From PCR London Valves 2025

This session provides an in-depth exploration of haemodynamic performance and valve durability following transcatheter aortic valve implantation (TAVI). Attendees will gain a comprehensive understanding of the differences between invasive and echocardiographic gradients post-TAVI, evaluate the haemodynamic profiles of various transcatheter valve platforms, and appreciate their implications...

TAVI for pure aortic regurgitation: different animal, different challenges, different approaches

17 Nov 2025 – From PCR London Valves 2025

This session delves into the unique anatomical and pathophysiological challenges posed by pure aortic regurgitation and their impact on treatment strategies. It reviews clinical outcomes with established and new transcatheter devices, and presents emerging technologies that promise to advance therapeutic options for this distinct patient population.

TAVI in patients with concomitant valve and coronary artery disease

17 Nov 2025 – From PCR London Valves 2025

Focused on patients with concomitant valve and coronary artery disease, this session examines evaluation strategies for aortic stenosis burden, integrates recent trial data on combined TAVI and PCI, and discusses optimal management approaches in complex multi-valve disease scenarios through detailed case presentations and clinical outcomes.

TAVI: LIVE Educational Case from St. Thomas' Hospital - London, UK

18 Nov 2025 – From PCR London Valves 2025

This educational session presents a live TAVI case from St. Thomas' Hospital in London, providing detailed insights into patient presentation, imaging analysis, operator strategy, and device selection. It includes a live procedural demonstration complemented by a recorded case from Erasmus University Medical Center in Rotterdam, offering...

The Top Late-Breaking Trials - Part 1

16 Nov 2025 – From PCR London Valves 2025

This session presents pivotal late-breaking trials in transcatheter mitral and aortic valve interventions. Explore one-year outcomes from the AltaValve early feasibility study featuring atrial fixation TMVR, interim results from the TARGET study assessing Cardiovalve for tricuspid regurgitation, five-year data on transapical TMVR, and outcomes of TAVI...

Transcatheter tricuspid valve replacement: LIVE Educational Case from St. Thomas' Hospital - London, UK

18 Nov 2025 – From PCR London Valves 2025

This educational session presents a live transcatheter tricuspid valve replacement case from St. Thomas' Hospital, London, complemented by detailed patient imaging analysis and operator strategy. Additionally, a recorded case from the Upper Silesian Medical Center in Poland provides further insights into procedural nuances and outcomes, offering...

Tricuspid interventions: knowns and unknowns

17 Nov 2025 – From PCR London Valves 2025

Explore the evolving landscape of transcatheter tricuspid valve interventions in this session, which presents the latest evidence from registries and randomized trials. Discussions include the new Euro tricuspid regurgitation risk score, clinical controversies, real-world patient scenarios, and insights into optimal medical therapy and device selection to...

iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation

04 Nov 2021

Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...

Nicola Ryan

Author

Nicola Ryan
iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

OCT insights of thrombus extraction by stent-retriever thrombectomy (SRT) and manual aspiration (MA): Insights from RETRIEVE AMI trial

29 Oct 2025

Aaysha Cader provides her take on sub-analyses of the RETRIEVE AMI trial presented by Jason Leo Walsh at TCT 2025, in San Francisco.

Author

Aaysha Cader
RETRIEVE AMI: OCT insights of SRT and MA

MERIL announces successful primary outcomes of next-gen Myval THV series in major RCT, presented at EuroPCR 2024 - Earns prestigious late Breaking trial status & The LANCET acceptance.

15 May 2024

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Sofie Brouwers

Author

Sofie Brouwers
Why hypertension is a major unresolved problem

TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

03 Sep 2025

Aaysha Cader provides her take on TACSI presented by Anders Jeppsson at ESC Congress 2025 in Madrid.

Author

Aaysha Cader
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

31 Aug 2021

Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.

Daniele Giacoppo

Author

Daniele Giacoppo
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
Didn’t find what you were looking for?